Lipoprotein (a). Options: targets and limitations.

21 April 2018 (12:30 - 12:50)

Organised by:

About the speaker

Professor Georg Ehret

University hospitals of Geneva, Geneva (Switzerland)

4 More presentations in this session

Presentation thumbnail

Angina in diabetes mellitus - The microvascular component.

Professor N. van Royen (Nijmegen, NL)

Presentation thumbnail

Role of microvessels in plaque formation in diabetes mellitus.

Professor L. Badimon (Barcelona, ES)

Presentation thumbnail

Dyslipidemia impairs high-density lipoprotein cardioprotective effects leading to larger infarcts

Doctor G. Vilahur (Barcelona, ES)

Presentation thumbnail

Panel discussion.

Access the full session

Session thumbnail

Translational aspects in metabolic disorders and micro- and macrovascular pathology

The Event

Frontiers in CardioVascular Biology 2018

21 April 2018 12:30 CET

You may be interested in

Congress Presentation

Review on clinical strategies for managing patients with elevated Lp(a): Cost-effectiveness of Lp(a) testing and awareness of lifestyle changes via Public Health Policy in absence of targeted therapy

24 June 2023

Congress Presentation

Discovery and preclinical development of LY3473329, a potent small molecule inhibitor of lipoprotein(a) formation

27 August 2023

ESC TV Today

Episode 26: Lp(a): the future starts now - Myocardial infarction in older age and frailty

6 November 2025

Congress Presentation

Impact of lipoprotein(a) as a residual risk on long-term cardiovascular outcomes in patients with acute coronary syndrome treated with statin

27 August 2021

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources